Cargando…
Glycoconjugation: An approach to cancer therapeutics
Cancer constitutes the second leading cause of death globally and is considered to have been responsible for an estimated 9.6 million fatalities in 2018. Although treatments against gastrointestinal tumors have recently advanced, those interventions can only be applied to a minority of patients at t...
Autores principales: | Molejon, Maria I, Weiz, Gisela, Breccia, Javier D, Vaccaro, Maria Ines |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103525/ https://www.ncbi.nlm.nih.gov/pubmed/32257842 http://dx.doi.org/10.5306/wjco.v11.i3.110 |
Ejemplares similares
-
Pyruvate Substitutions on Glycoconjugates
por: Hager, Fiona F., et al.
Publicado: (2019) -
Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021) -
Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015) -
Recent Advances in the Chemistry of Glycoconjugate Amphiphiles
por: Latxague, Laurent, et al.
Publicado: (2018) -
Sterol and Sphingoid Glycoconjugates from Microalgae
por: Stonik, Valentin A., et al.
Publicado: (2018)